Pasithea Therapeutics (KTTA) Operating Leases (2022 - 2024)
Pasithea Therapeutics (KTTA) posted Operating Leases of $32989.0 for Q1 2024, down 59.61% sequentially from $81680.0 in Q4 2023, and down 89.02% YoY from $300480.0 in Q2 2023.
Pasithea Therapeutics (KTTA) Operating Leases (2022 - 2024) Analysis & Trends
Pasithea Therapeutics has reported Operating Leases for 3 years, with the latest figure at $32989.0 in Q1 2024.
- Quarterly Operating Leases fell 89.02% year-over-year to $32989.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $32989.0 (down 89.02% YoY) and the FY2023 annual result came in at $81680.0, down 76.26% from the prior year.
- Operating Leases declined to $32989.0 in Q1 2024 per KTTA's latest filing, from $81680.0 in the prior quarter.
- Over five years, Operating Leases peaked at $724386.0 in Q3 2022 and troughed at $32989.0 in Q1 2024.
- A 3-year average of $331606.1 and a median of $351133.0 in 2022 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2024: Operating Leases increased 18.85% in 2023, then plunged 89.02% in 2024.
- Over 3 years, Operating Leases stood at $344021.0 in 2022, then sank by 76.26% to $81680.0 in 2023, then plunged by 59.61% to $32989.0 in 2024.
- According to Business Quant data, Operating Leases over the past three periods registered $32989.0, $81680.0, and $385288.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pasithea Therapeutics | 16.97 Mn | 16.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 32,989.00 |
| Dec 31, 2023 | 81,680.00 |
| Sep 30, 2023 | 385,288.00 |
| Jun 30, 2023 | 425,760.00 |
| Mar 31, 2023 | 300,480.00 |
| Dec 31, 2022 | 344,021.00 |
| Sep 30, 2022 | 724,386.00 |
| Jun 30, 2022 | 358,245.00 |